Thu, December 26, 2019
Tue, December 24, 2019
Mon, December 23, 2019
Fri, December 20, 2019
Thu, December 19, 2019
Wed, December 18, 2019
Tue, December 17, 2019
Mon, December 16, 2019
Fri, December 13, 2019
Thu, December 12, 2019
Wed, December 11, 2019
Tue, December 10, 2019

David Lebovitz Maintained (ASND) at Buy with Increased Target to $140 on, Dec 17th, 2019


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-140-on-dec-17th-2019.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebovitz of Morgan Stanley, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Increased Target from $134 to $140 on, Dec 17th, 2019.

David has made no other calls on ASND in the last 4 months.



There are 2 other peers that have a rating on ASND. Out of the 2 peers that are also analyzing ASND, 0 agree with David's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with David


  • Liana Moussatos of "Wedbush" Maintained at Buy with Decreased Target to $186 on, Tuesday, October 22nd, 2019
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $152 on, Thursday, August 29th, 2019

Publication Contributing Sources